1/3

FIEO Registered Export Ready

Maziclav-625

Name: Maziclav-625
SKU: 8238672
Availability: InStoreOnly

Sold by freedom healthcare private limited · Brand Owner, Distributor, Wholesaler, Women Entrepreneur · Jaipur, Rajasthan, India

Price

Price on request

In stock

Inclusive of all taxes

Minimum order: 1 Centimetre

Export Snapshot

MOQ

1 Centimetre

Lead time

On request

Packaging

Blister packs or bottles, customizable based on order

Shelf life / longevity

As per product specification

HSN Code

On request

Origin

India

Port of dispatch

On request

Export markets served

Global markets

Values shown are for freedom healthcare private limited.

FIEO Registered

Suitable for

Importers · Distributors · Wholesalers

Jaipur Dispatch on request FIEO member

freedom healthcare private limited

Brand Owner, Distributor, Wholesaler, Women Entrepreneur · Jaipur, Rajasthan, India

In the vibrant tapestry of healthcare, Freedom Healthcare Private Limited emerged as a beacon of hope in 2013, when Jitender Mohan Kamra, driven by a profound desire to serve humanity with quality medication, laid the foundation of the company. Nestled in the heart of Rajasthan, the company swiftly expanded its wings, establishing a robust presence in Delhi, Punjab, and Haryana. Jitender Mohan Kamra's vision was simple yet profound – to bring about a positive change in people's lives through accessible and reliable healthcare. With unwavering dedication, Freedom Healthcare began its journey, crafting a legacy that transcended business and resonated with compassion. Over the years, Freedom Healthcare not only garnered trust and loyalty but also became synonymous with excellence in pharmaceuticals. The company's commitment to quality and integrity endeared it to healthcare professionals and communities alike. As the years rolled by, a heartwarming twist unfolded in the company's narrative. Jitender Mohan Kamra's children, inspired by their father's noble cause, embraced the legacy with open arms. Fueled by the same passion and commitment, they joined the company, becoming torchbearers of the Freedom Healthcare ethos. The legacy of Freedom Healthcare is no longer confined to a single visionary; it now thrives through the collective efforts of a family united by a shared purpose. The seamless blend of tradition and innovation has propelled the company to new heights, ensuring

Registered address: Jaipur, India. Industry: Healthcare, Medical Supplies & Pharmaceuticals > Health Care Products.

View profile All products

Established

2013

Employees

31–50

GST

08AACCF4091M1ZB

IEC code

AACCF4091M

Export markets

Global markets

GlobalLinker Member Since

Dec 2023

Turnover

Less than $50,000

Incorporation Type

On request

Certifications & Awards

Product details

What are the specifications of this product?

Overview

Revolutionize the battle against resistant bacteria with MAZICLAV-625. Our groundbreaking formula dismantles the shield of resistance, swiftly eliminating bacterial threats. Backed by cutting-edge technology and relentless research, MAZICLAV-625 stands as the pinnacle of bactericidal innovation. Elevate your approach to combating infections by choosing MAZICLAV-625 – the trusted ally in breaking the barriers of resistance.

Product Description

MAZICLAV-625

Amoxycillin 500 mg + Potassium Clavulanate 125 mg Tablets

Amoxycillin

Broad spectrum of bactericidal activity against many gram-positive and gram-negative micro organism

Potassium Clavulanate

Activity against the clinically important plasmid-mediated

B-lactamases frequently responsible for transferred drug resistance.

MAZICLAV-625 combines amoxicillin and clavulanic acid to deliver broad-spectrum action against resistant pathogens. Ideal for respiratory, urinary, skin, and soft tissue infections, it ensures rapid bacterial clearance and clinical recovery. Its advanced formulation enhances bioavailability and patient compliance. Backed by clinical studies and expert endorsement, MAZICLAV-625 is your frontline defense in antibiotic therapy. Trust in its proven efficacy, minimal side effects, and consistent performance to redefine treatment standards in resistant bacterial infections.

Description provided by freedom healthcare private limited.

Specifications

Dosage Strength	625 mg per tablet (500 mg Amoxycillin + 125 mg Potassium Clavulanate)
Dosage Form	Tablet
Route of Administration	Oral
Physicochemical Properties	White to off-white, round, biconvex tablet
Packaging	Blister packs or bottles, customizable based on order
Shelf Life	Typically 2 years from manufacturing
Storage Conditions	Store in a cool, dry place away from direct sunlight
Pharmacokinetics	Enhanced bioavailability due to clavulanate component
Regulatory Compliance	Manufactured following GMP guidelines
Manufacturer	Available upon inquiry (specific manufacturer details)
Target Market	Healthcare providers and pharmaceutical distributors

Use cases

Category	healthcare > drugs and medicine > animal medicines and healthcare > veterinary medicines
Primary application	Wholesale, distribution, and international sourcing
Brand	Not specified
Product type	Product

Logistics & handling

Lead time	On request
Packaging	Blister packs or bottles, customizable based on order
Storage condition	As recommended by supplier
Origin	India
Form	As listed by supplier

Commercials (this seller)

Minimum order	1 Centimetre
Lead time	On request
Payment terms	As per negotiated commercial agreement.

Buyer questions

Frequently asked by buyers

Common questions B2B buyers ask before sourcing Maziclav-625. Answers compiled from verified sellers' commercial terms and platform data.

Q: How does Maziclav-625 overcome bacterial resistance compared to standard Amoxycillin?

A: Maziclav-625 contains Potassium Clavulanate, which inhibits beta-lactamase enzymes that many resistant bacteria produce, thereby protecting Amoxycillin from degradation and restoring its bactericidal effectiveness.

Q: What types of infections are best treated with Maziclav-625?

A: Maziclav-625 is specifically effective against infections of the respiratory tract, urinary tract, skin, and soft tissues caused by both gram-positive and gram-negative bacteria including beta-lactamase producing strains.

Q: Is Maziclav-625 suitable for outpatient therapy in terms of dosing and compliance?

A: Yes, the formulation of Maziclav-625 is designed for enhanced bioavailability and ease of administration, which promotes better patient compliance and suitability for outpatient treatment regimens.

Q: Does Maziclav-625 have any advantages in pharmacokinetics over other Amoxycillin-Clavulanate combinations?

A: The advanced formulation of Maziclav-625 ensures improved absorption and bioavailability, enabling rapid bacterial clearance and faster clinical recovery compared to older formulations.

Q: What quality standards does Maziclav-625 adhere to in manufacturing?

A: Maziclav-625 is manufactured in compliance with GMP guidelines ensuring high-quality, safe, and consistently effective antibiotic tablets.

Question not answered? Ask sellers directly — typical response within 4 hours.